| 29 April 2014 | |||||||||
| RA challenges in the biologic era | Sjögren's | Partnerships in primary care | International challenges | Physical activity in OA | Education oral abstracts | Osteoporosis SIG | BHPR CTD SIG | ||
| Coffee, exhibition, poster viewing and Innovation theatre: Roche Products Ltd and Chugai Pharma UK Ltd | |||||||||
| Flare in RA | Biosimilars in perspective | Primary care - oral abstracts | Thirty years of BSR | Public & patient involvement | OA and Bone oral abstracts | Myositis SIG | Polymyalgia SIG | ||
| Lunch and Innovation theatre: AbbVie Ltd | BSR Biologics Registers meeting | PHD student networking | |||||||
| Jewels in the Crown | |||||||||
| Coffee and exhibition | |||||||||
| Heberden round | |||||||||
| Industry supported symposium - MSD | Industry supported symposium - Bristol Myers Squibb | ||||||||
| 30th Anniversary dinner and Presidents' reception | |||||||||
| 30 April 2014 | |||||||||||||
| Industry supported symposium - Janssen | Industry supported symposium - A.Menarini Farmaceutica Internazionale SRL | ||||||||||||
| Fibro- myalgia | Mgmt of difficult Lupus | Essentials: Disease mgmt | Fatigue | Tropical medicine 1 | SpA SIG | Rheumatoid arthritis oral abstracts | |||||||
| Coffee, exhibition, poster viewing and Innovation Sessions: Celgene | |||||||||||||
| OA therapeutics | SpA update | Essentials: Managing symptoms & patients | BHPR oral abstracts | Tropical medicine 2 | Inflammatory arthritis and comorbidities oral abstracts | Sjögren’s syndrome SIG | Musculoskeletal pain SIG | ||||||
| Lunch and Innovation Sessions: UCB, Janssen | BSR/BHPR AGM | ||||||||||||
| Pain (CRPS) | Lung in RA | Essentials: Clinical decision making | Back pain | Tropical medicine 3 | ARMA MSK clinical networks | BHPR MSK SIG | Osteoarthritis SIG | ||||||
| Coffee and exhibition | |||||||||||||
| Heberden Oration | |||||||||||||
| Industry supported symposium: Roche Products Ltd and Chugai Pharma UK Ltd | Industry supported symposium: AbbVie Ltd | ||||||||||||


